The global lung cancer surgery market was estimated to be worth US$ 1.23 billion in 2021 and is projected to increase to US$ 1.98 billion by 2029, according to a recent market study by Future Market Insights (FMI).Robotic thoracic surgery would continue to be preferred over traditional surgical techniques because it.
According to a recent market study by Future Market Insights (FMI), the global market for lung cancer surgery was valued at US$ 1.23 billion in 2021 and is projected to grow to US$ 1.98 billion by 2029.Over 2 million new cases of lung cancer were registered globally by the end of 2021, as reported by the American Ca.
Over 2 million new cases of lung cancer were registered globally by the end of 2021, as reported by the American Cancer Society, Inc. The global lung cancer surgery landscape currently represents a US$ 1 Bn market and will expand at a strong CAGR during the period of projection, 2022 – 2029. A new Future Market Insi.
Share:
New York, March 08, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Surgical Energy Instruments (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) - https://www.reportlinker.com/p05948843/?utm source=GNW
The model discusses in detail the impact of COVID-19 on Surgical Energy Instruments market for the year 2020 and beyond.Surgical Energy is used in numerous procedures spanning across multiple therapeutic areas and fields of expertise.
In regard to General Surgery, surgical energy is utilized whenever tissue needs to be cut, coagulated or sealed with minimal blood loss.The procedures include open surgery and laparoscopic surgeries and can be used in specific procedures covered under OB-GYN, urology, oncology, cardiovascular, etc.